RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (MARKET WIRE) -- March 13, 2007 -- Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today announced its corporate and clinical goals for 2007 following the recently completed public financing for US$25 million in gross proceeds. The Company will hold a corporate update conference call to discuss these corporate and clinical goals on Thursday, March 15, 2007 at 10 a.m. ET.
